– UK, Village Alva – Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Colin King has agreed to join the Board as Chief Operating Officer and will take up his appointment with effect from 3 August 2015.
Mr King has over 20 years’ experience in the in-vitro diagnostics industry and is currently the Managing Director of Axis-Shield Diagnostics, having joined in 1995 and held a number of positions encompassing project management, operations, planning and supply chain logistics.
Andrew Shepherd, Chief Executive of the Company said:”We would like to welcome Colin to the Board. He brings a wealth of relevant industry experience and his depth of knowledge of the in-vitro diagnostics sector will further strengthen the Omega Board.”
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.